Search results
Showing 5026 to 5040 of 8314 results
Recommendation ID NG22/2 Question Service delivery models:- Which models of service delivery are effective and cost-effective for older
Recommendation ID CG151/1 Question Service provision for neutropenic sepsis in patients with cancer:- A prospective national cohort study
Recommendation ID CG136/3 Question Shared decision-making:- For people using adult mental health services, what are the key aspects of
Recommendation ID NG128/06 Question Aspirin treatment in acute ischaemic stroke: Should a person who has a stroke or a TIA and is already
Recommendation ID NG181/7 Question What staff training interventions are effective at facilitating personal recovery for people with complex
Recommendation ID CG151/3 Question Signs and symptoms that predict neutropenic sepsis in the community:- A prospective study should be
Recommendation ID NG238/1 Question What is the effectiveness of age alone and other routinely available risk factors compared with the
Recommendation ID NG180/7 Question What is the most clinically and cost-effective timing and dose of a single administration of gabapentin
Recommendation ID CG139/1 Question Standard principles of infection prevention and control:- What are the barriers to compliance with the
Recommendation ID NG198/4 Question What skin care advice is appropriate for people with acne? Any explanatory notes(if applicable)
Recommendation ID IPG666/1 Question NICE may update this guidance after 3 years or sooner if important new information becomes available
Recommendation ID NG30/2 Question Reducing use of emergency dental care:- What interventions are effective and cost effective at encouraging
Recommendation ID NG19/2 Question When and with what criteria should people with diabetes be referred to the foot protection service or
Recommendation ID NG19/2 Question Referral criteria for the foot protection service and the multidisciplinary foot care service:- When
Recommendation ID NG81/5 Question Referral filtering:- What is the effectiveness and cost effectiveness of the different models for glaucoma